Inactive Instrument
Precision Therapeutics Inc Stock Nasdaq
Stocks
US74033P1003
Biotechnology & Medical Research
| Market Cap | 111M 95.28M 89.15M 81.6M 153M 10.64B 155M 1.05B 411M 5.35B 418M 409M 17.68B | P/E 2024 |
-0.35x | P/E 2025 | -0.53x |
|---|---|---|---|---|---|
| Enterprise Value | 102M 87.46M 81.83M 74.91M 141M 9.77B 142M 967M 377M 4.91B 383M 375M 16.23B | EV / Sales 2024 |
4.23x | EV / Sales 2025 | 121x |
| Free-Float |
94.39% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Precision Therapeutics Inc
| 1 day | -7.56% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 09/02/2026 | |
| Director of Finance/CFO | - | 16/04/2026 | |
Kyle Okamoto
PSD | President | - | 01/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel Handley
BRD | Director/Board Member | 66 | 19/02/2020 |
Charles L. Nuzum
CHM | Chairman | 78 | 09/02/2026 |
| Director/Board Member | 60 | 09/07/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -7.56% | -8.33% | - | - | 111M | ||
| +1.09% | +5.26% | +4.44% | +26.03% | 51.22B | ||
| -1.32% | +2.49% | +472.31% | +598.96% | 45.38B | ||
| +2.24% | +8.63% | +20.22% | +92.46% | 41.97B | ||
| +0.72% | +9.35% | +39.59% | +20.73% | 42.15B | ||
| -0.93% | -4.80% | +17.39% | +46.60% | 31.95B | ||
| +0.29% | +3.14% | - | - | 16.73B | ||
| +2.05% | +7.90% | +37.70% | +153.77% | 17.1B | ||
| +0.03% | +3.41% | +7.12% | +35.49% | 14.76B | ||
| +1.85% | +6.07% | +92.21% | +47.85% | 13.91B | ||
| Average | -0.16% | +3.19% | +86.37% | +127.74% | 30.58B | |
| Weighted average by Cap. | +0.56% | +3.13% | +103.57% | +149.27% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.62M 1.39M 1.3M 1.19M 2.24M 155M 2.27M 15.38M 6M 78.05M 6.1M 5.96M 258M | 125K 107K 100K 91.92K 173K 11.99M 175K 1.19M 463K 6.02M 470K 460K 19.92M |
| Net income | -12.66M -10.85M -10.15M -9.29M -17.44M -1.21B -17.67M -120M -46.77M -609M -47.55M -46.52M -2.01B | -233M -200M -187M -171M -321M -22.3B -325M -2.21B -861M -11.2B -875M -856M -37.06B |
| Net Debt | 1.4M 1.2M 1.12M 1.02M 1.92M 134M 1.95M 13.22M 5.16M 67.11M 5.24M 5.13M 222M | -9.12M -7.82M -7.31M -6.69M -12.56M -873M -12.73M -86.41M -33.7M -439M -34.26M -33.52M -1.45B |
Employees
-

















